Maalox

Aajonus identified Maalox as chalk, dolomite, calcium-dense pulverized rock, or "bindolamine, which is rock with a high degree of calcium in it." He described it as liquid chalk and said it was highly alkaline. He used all of these terms across different tellings of the same account, but the consistent characterization was that it is a mineral substance mined from rock, processed into a drinkable liquid, and used medicinally to neutralize stomach acid.

He pointed out that 98% of digestive bacteria is acidic, and that introducing a highly alkaline substance into the digestive environment neutralizes not just the hydrochloric acid responsible for the ulcer but the entire acid environment necessary for digestion. The result, in his account, was that he stopped digesting anything while taking Maalox.

The core mechanism Aajonus described is straightforward within his framework: hydrochloric acid is what digests protein. When Maalox absorbs all available hydrochloric acid, the body loses the capacity to break down meat, dairy, and any other animal proteins. He stated this flatly and repeatedly, saying things like "you don't digest meat, you don't digest protein, that's basically the therapy."

He extended this further, noting that the Maalox did not merely suppress acid temporarily but that the absence of acid meant food sat in the stomach and digestive tract without being properly broken down. The body could not extract nutrients needed to repair the ulcerated tissue. The treatment that was supposed to allow the ulcer to heal by removing the irritant of acid simultaneously removed the biological means by which healing tissue is built and maintained. From his perspective, the pharmaceutical approach addressed one visible problem while creating a deeper systemic one.

He also noted that some acid continued to seep past the Maalox before being absorbed, so he still experienced pain and burning during the treatment period, while simultaneously being unable to digest his food.

Aajonus stated across numerous accounts that the tumor which grew adjacent to his ulcer was caused directly by drinking Maalox, not by the ulcer itself or the conditions that caused the ulcer. He described several mechanisms by which this occurred.

In one account he said Maalox "hardens tissue," and that this hardening at the ulcer site was what produced the tumor. In another telling he said it "dries everything up" and "puts a plastic coating over your hole," which stopped the bleeding but created an abnormal tissue environment. In yet another account he described Maalox pulling calcium, magnesium, and potassium out of the body and imbalancing mineral levels, which he said made him "very violent during that period from those imbalances," while the tumor was "growing very rapidly."

He also described Maalox leaving "lots of residual problems" beyond the immediate digestive suppression, characterizing the mineral imbalances as a systemic consequence of taking a highly alkaline calcium-dense substance in large quantities over six months. The tumor, in his framing, was a direct consequence of what Maalox does to tissue when consumed chronically and in large volumes.

Aajonus gave varying specific figures for how much Maalox he consumed across different accounts, and these figures differ somewhat depending on the telling. He described consuming:

A bottle a day at peak consumption. Two bottles a week as a more sustained average. Five bottles a week during certain periods. Two bottles a week described as typical in some accounts. Six months as the total duration of Maalox treatment before the tumor appeared.

He used phrases like "sometimes a bottle a day, sometimes two bottles a week" in the same accounts to capture variability in his consumption. The consistent point across all versions is that the quantity was large, sustained over months, and that he had been told by physicians to take Maalox whenever he experienced discomfort with no restrictions on how much.

Once the tumor was discovered adjacent to the ulcer, physicians told Aajonus it needed to be surgically removed before it could block the esophagus and prevent eating entirely. This led directly to the vagotomy pyloroplasty procedure, which Aajonus described as the medical response to the consequence of the Maalox treatment. In his framing, the Maalox caused the tumor, and the tumor caused the surgery, making the surgery a downstream result of pharmaceutical treatment rather than of the original condition.

The vagotomy severed all vagus nerves to the stomach, permanently eliminating his ability to ever again secrete hydrochloric acid. The pyloroplasty stretched the duodenum to three times its normal size, converting it to scar tissue, with the stated rationale of holding food longer to absorb more acid. He pointed out the internal contradiction of this: the vagotomy had just eliminated hydrochloric acid production entirely, so stretching the duodenum to absorb more acid served no logical purpose. He said of this, "if you severed the nerves, I don't have any hydrochloric acid, why did you do the vagotomy? It doesn't make any freaking sense, but that's what they did."

The surgery placed him "in the category of octogenarians" who do not secrete hydrochloric acid and cannot digest protein, requiring liquid foods and prohibiting even raw fruits unless heated, cooked, or steamed. The surgery became tumorous in turn, the incision scar becoming cancerous from stem to stomach, which was then irradiated, which he said gave him blood and bone cancer.

Aajonus framed the entire Maalox intervention as a pharmaceutical misdirection that addressed the wrong problem. He described the correct question as: what would cause someone not to produce enough mucus to protect the stomach lining? The stomach lining is protected by mucus, and when that mucus is insufficient, the body's own hydrochloric acid digests the stomach wall. The causative agents in his case were alcohol, nicotine, and caffeine, all of which robbed the body of mucus, leaving the lining unprotected.

He said the logical medical intervention would have been to give the patient something to speed the production of mucus on the stomach lining. Instead, the response was to go immediately to Maalox to cut out the acid, which meant protein could no longer be digested at all, and healing tissue could not be built. He described this as a failure to address the cause and a decision to address only the symptom in a way that made the underlying condition worse.

He also noted that the ulcer could not heal even from a basic biological standpoint while Maalox was being taken, because healing tissue requires nutrients derived from digested food, and Maalox eliminated the capacity to digest food. He said directly: "that doesn't mean your ulcer will heal because you're not able to digest any foods to heal."

Aajonus used his own Maalox experience as a demonstration of what he saw as the pharmaceutical industry's fundamental operating principle: creating dependency rather than resolution. He drew a direct parallel between the addictive elements in cigarettes, noting that 42 of 68 elements in cigarettes exist to maintain addiction, and what he characterized as the pharmaceutical industry's design to keep patients on medication.

He said Maalox "didn't help," made him worse, and led to the tumor, which led to the surgery, which led to the incision going tumorous, which led to radiation, which led to blood and bone cancer. Each intervention, in his account, created the conditions requiring the next intervention, and none addressed the original cause. He described the physician response to the ulcer as not even considering the first step, which would have been supporting mucus production, and going directly to acid suppression, which eliminated digestion entirely.

He also said the pharmaceutical industry does not want anyone cured because a cured patient no longer generates revenue. He contrasted this with what he described as the reality of the ulcer situation: the milk alternative, mentioned in passing in a medical column he referenced, which simply said to drink whole milk, was a nutritive approach that could have addressed the problem without eliminating digestion. Instead Maalox was prescribed in unlimited quantities with no lifestyle restrictions.

Aajonus consistently presented his Maalox experience as the pivotal pharmaceutical intervention that set in motion a cascade of medical consequences spanning decades. Before Maalox he had an ulcer. After Maalox he had a tumor. After surgery for the tumor he had a tumorous incision. After radiation for the incision he had blood and bone cancer. After chemotherapy, including AZT which he said was outlawed a year after being given to him for being too toxic for humans, he had further systemic collapse.

He also noted that his severed vagus nerve had a consequence discovered later, when he ate a poisonous mushroom and could not vomit because the vagus nerve to the stomach had been surgically cut. He observed that the vagus nerve is the mechanism through which the body rejects ingested poisons via vomiting, and that his surgery had permanently disabled this protective reflex.

His account of Maalox was not limited to a complaint about one bad drug. It was the opening chapter in a long narrative about how pharmaceutical medicine responds to symptoms rather than causes, creates downstream harms greater than the original condition, and is structured around maintaining patient dependency rather than restoring health.

---